Over the past few years, a combination of supply chain issues and rising diagnoses of attention-deficit hyperactivity disorder (ADHD) has led to a major shortage of medicines focused on treating individuals with the disorder. As a result, top MPH products, such as Ritalin and Concerta, have started facing supply shortages as well.2,5,6There has been major implication for the shortage, especially among children who rely on various ADHD medications to focus during the school day. Because ADHD medications are controlled substances, prescriptions have to be filled monthly because only one 30-day supply is distributed at a time.7"This is very different than any other medication shortage. "Because of these shortages, we have children who have to jump from one medicine to the other, and every month, every week. According to the statement, they are "working closely with numerous manufacturers, agencies, and others in the supply chain to understand, prevent, and reduce the impact of these shortages."

Source: Forbes November 03, 2023 18:44 UTC